Published in Rev Fr Transfus on July 01, 1968
Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA (1997) 5.85
Summertime haze air pollution and children with asthma. Am J Respir Crit Care Med (1997) 2.28
Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med (1999) 2.09
The role of titratable acidity in acid aerosol-induced bronchoconstriction. Am Rev Respir Dis (1987) 1.44
Additional data on the population distribution of human serum albumin genes; three new variants. Ann Hum Genet (1973) 1.35
A simple technique for the isolation of monoclonal IgG and IgA. Rev Eur Etud Clin Biol (1970) 1.14
Immunoglobulins and transferrin in marine lamprey sera. Nature (1967) 1.11
Selective serum IgA deficiency. Frequency among 15,200 French blood donors. Vox Sang (1973) 1.10
A statewide initiative to improve the care of hospitalized pneumonia patients: The Connecticut Pneumonia Pathway Project. Am J Med (2001) 1.07
Frequency of monoclonal gammapathy ('M components') in 13,400 sera from blood donors. Vox Sang (1972) 1.04
Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diath Haemorrh Suppl (1965) 1.02
Intravascular coagulation and heparin therapy in acute renal failure: a reappraisal. Rev Eur Etud Clin Biol (1973) 1.01
[Various molecular states of factor II (prothrombin). Their study by means of staphylocoagulase and anti-factor II antibodies. I. Factor II in patients treated with vitamin K antagonists]. Thromb Diath Haemorrh (1968) 0.99
Coagulation studies in 45 cases of nephrotic syndrome without uremia. Thromb Diath Haemorrh (1970) 0.99
Molecular weight estimation of proteins by electrophoresis in linear polyacrylamide gradient gels in the absence of denaturing agents. Anal Biochem (1979) 0.98
A new method for determination of molecular weights of proteins by electrophoresis across a sodium dodecyl sulfate (SDS)-polyacrylamide gradient gel. Anal Biochem (1976) 0.98
Metal fume fever. Occup Med (1994) 0.97
Pulmonary effects of inhaled zinc oxide in human subjects, guinea pigs, rats, and rabbits. Am Ind Hyg Assoc J (1992) 0.95
[Coagulation factor VII deficiency in 3 patients with trisomy 8]. Ann Genet (1974) 0.94
[Antiproteinase activity of alpha-2-macroglobulin. II. Its role in progressive antithrombin states]. Rev Fr Etud Clin Biol (1968) 0.93
Monoclonal gammopathies in asymptomatic HIV-seropositive patients. Clin Chem (1987) 0.93
Human albumin genetic variants: an attempt at a classification of European allotypes. Am J Hum Genet (1987) 0.93
Alpha-2-macroglobulin as progressive antithrombin. Nature (1967) 0.90
["Essential" dysglobulinemia in aged subjects]. Nouv Rev Fr Hematol (1966) 0.90
Structural characterization of the human albumin variant "Pollibauer". Rev Fr Transfus Immunohematol (1984) 0.90
Malignant evolution of asymptomatic monoclonal IgM after seven and fifteen years in two siblings of a patient with Waldenström's macroglobulinemia. Acta Med Scand (1982) 0.90
Acidity potentiates bronchoconstriction induced by hypoosmolar aerosols. Am Rev Respir Dis (1988) 0.88
Anti-DNA autoantibody activity and idiotypic relationships of human monoclonal proteins. Eur J Immunol (1984) 0.88
Symptomatic bronchoconstriction after short-term inhalation of sulfur dioxide. Am Rev Respir Dis (1987) 0.88
Study of the frequency of kappa and lambda light chains in 347 sera containing a monoclonal IgG, IgA, IgD, or Bence-Jones protein. Rev Eur Etud Clin Biol (1970) 0.87
Identification of the human albumin variant "Gainesville" with proalbumin "Christchurch". Rev Fr Transfus Immunohematol (1983) 0.86
Evolution of blood clotting factor leves in premature infants during the first 10 days of life: a study of 96 cases with comparison between clinical status and blood clotting factor levels. Pediatr Res (1973) 0.86
Systematic survey of monoclonal gammapathies in the sera from blood donors. Transfusion (1979) 0.85
Antibody-induced von Willebrand syndrome: inhibition of VIII VWF and VIII AGN with sparing of VIII AHF by the autoantibody. Am J Hematol (1978) 0.83
Potential bronchoconstrictor stimuli in acid fog. Environ Health Perspect (1989) 0.82
[Studies on monoclonal IgG. I. Isolation method based on the solubility of these proteins, and study, by electrophoresis in starch-urea gel, of reduction-alkylation products of these immunoglobulins]. Rev Fr Transfus (1970) 0.82
Follow-up of monoclonal gammopathies in asymptomatic HIV-infected subjects. Clin Chem (1989) 0.82
Serum neopterin and beta 2-microglobulin in anti-HIV positive blood donors. Lancet (1986) 0.82
Tissue factor activity of cultured human lymphocytes. Biomedicine (1975) 0.82
Interspecies differences in the phagocytic activity of pulmonary macrophages subjected to acidic challenge. Fundam Appl Toxicol (1992) 0.82
[Genetic variants of human albumin: structural characterization of allotypes used as references for electrophoretic classification]. Rev Fr Transfus Immunohematol (1988) 0.82
A human monoclonal IgG1 with anti-idiotypic activity against anti-human thyroglobulin autoantibody. J Immunol (1984) 0.81
[Initiation in vivo of blood coagulation. The role of white blood cells and tissue factor (author's transl)]. Nouv Presse Med (1979) 0.81
Monoclonal IgD. A comparative study of 60 sera with IgD "M" component. Biomedicine (1974) 0.81
[Myeloma with a serum gammaG paraprotein and urinary elimination of a fragment of gammaG devoid of light chains]. Rev Fr Etud Clin Biol (1968) 0.81
Congenital abnormality of the prothrombin molecule (factor II) in four siblings: prothrombin Barcelona. Blood (1971) 0.80
The procoagulant factor of leukaemic promyelocytes: demonstration of immunologic cross reactivity with human brain tissue factor. Br J Haematol (1975) 0.80
Waldenström's macroglobulinemia in monozygotic twins. Acta Med Scand (1986) 0.80
IgG monoclonal gammapathy in the sister of a patient with Waldenström's macroglobulinaemia. Biomedicine (1973) 0.80
[Studies on human alpha-2 macroglobulin structure and its complexes with proteases, using polyacrylamide gel electrophoresis]. Rev Fr Transfus Immunohematol (1975) 0.80
[Survival in man of radioactive iodine labelled prothrombin (I-131)]. Rev Fr Transfus (1968) 0.79
[Immunologic study of human prothrombin and thrombin]. Thromb Diath Haemorrh (1967) 0.79
[Current aspects of the diagnosis of the dysglobulinemias (monoclonal hypergammaglobulinemias)]. Transfusion (Paris) (1967) 0.79
Apparent effect of catalase on airway edema in guinea pigs. Role of endotoxin contamination. Am Rev Respir Dis (1987) 0.79
[Allotypes of human albumin. Study of 8 cases of bisalbuminemia observed in France]. Rev Eur Etud Clin Biol (1970) 0.79
Antithrombin III versus prothrombin in liver cirrhosis. Haemostasis (1981) 0.79
Albumin Vanves: a new fast-moving variant of European origin. Hum Hered (1982) 0.79
[Recent data on monoclonal gammopathies]. Rev Fr Transfus Immunohematol (1985) 0.79
Removal of sedimentation decreases relative deposition of coarse particles in the lung periphery. J Appl Physiol (1985) (2013) 0.78
Occurrence of normal circulating proalbumin in a hemophilic A patient after acute hepatitis related to the delta virus. Clin Chem (1986) 0.78
Neopterin and beta 2-microglobulin in serum of HIV-seropositive subjects during a two-year follow-up. Clin Chem (1988) 0.78
Human albumin variants. Nomenclature of allotypes observed in Europe and quantitative estimation of their relative mobilities. Rev Fr Transfus Immunohematol (1982) 0.78
Size heterogeneity of human IgA myeloma proteins. Relationships between polymers and "J" chain. Biomedicine (1973) 0.78
Factors inhibiting use of the pneumococcal polysaccharide vaccine: a survey of Connecticut physicians. Conn Med (1998) 0.77
Recombinant human DNase in management of lobar atelectasis due to retained secretions. Thorax (1995) 0.77
Abnormal activation of a human prothrombin variant: prothrombin Barcelona. FEBS Lett (1978) 0.77
Purification and partial characterization of a new variant of human prothrombin: prothrombin Metz. FEBS Lett (1979) 0.77
Inhibition of plasmin by a small molecular weight inhibitor derived from human inter alpha trypsin inhibitor. Thromb Res (1978) 0.77
[High molecular-weight polymers in human albumin solutions. Quantitative determination by polyacrylamide gradient electrophoresis]. Rev Fr Transfus Immunohematol (1982) 0.77
HLA-A, B antigens and asymptomatic monoclonal gammopathy. Tissue Antigens (1983) 0.77
Distribution of heavy chain classes and light chain types in 757 cases of monoclonal gammapathies. Biomedicine (1975) 0.77
[Monoclonal macroglobulinemia of familial nature present in 3 siblings]. Transfusion (Paris) (1966) 0.77
[Groups of transferrins in the Anguilla species. Differences in the phenotypic frequencies of transferrins in Anguilla anguilla and Anguilla rostrata]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.76
Evolution towards AIDS in HIV-infected individuals. Lancet (1988) 0.76
Increased IgA as a predictor of development of AIDS in HIV-infected subjects. Clin Chem (1988) 0.76
Sarcoidosis complicated by HIV infection: three case reports and a review of the literature. Am Rev Respir Dis (1990) 0.76
Sarcoidosis and HIV infection. Chest (1994) 0.75
[Study of the coagulation with measurement of the catabolism of marked fibrinogen in Moschkowicz's disease]. Ann Pediatr (Paris) (1969) 0.75
Human prothrombin: a new method of preparation from a single individual. Thromb Diath Haemorrh (1973) 0.75
[Unusual leukemic syndrome in a newborn with 21 trisomy: megakaryocyte and platelet proliferation; disseminated intravascular coagulation syndrome]. Nouv Rev Fr Hematol (1974) 0.75
[Demonstration and isolation of the transferrin of the sea lamprey (Petromyzon marinus L.)]. C R Acad Sci Hebd Seances Acad Sci D (1966) 0.75
[Global coagulability in vitro of capillary blood. Applicaton to the jurveillance heparin therapy in children]. Pathol Biol (Paris) (1974) 0.75
Tentative immunochemical analysis of the prothrombin molecule. Pathol Biol (Paris) (1972) 0.75
[Disseminated intravascular coagulation in 49 patients with acute kidney failure]. J Urol Nephrol (Paris) (1972) 0.75
[Relationship between hemolytic action and lecithinase activity of Naja nigricollis venom]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.75
[Are the androgens effective in the treatment of medullary aplasias?]. Presse Med (1967) 0.75
Intravascular coagulation and nephropathies. Adv Nephrol Necker Hosp (1974) 0.75
Preparation and clinical use of P.P.S.B. (factors II, VII, X and IX concentrate). Thromb Diath Haemorrh Suppl (1968) 0.75
[On coagulation and catabolism of labelled fibrinogen during Moschkowicz's disease]. Arch Fr Pediatr (1969) 0.75
[Antiplasmin, antitrypsin and antithrombin activity of alpha-2-macroglobulin]. Transfusion (Paris) (1967) 0.75
[Coagulation disorders during acute leukemias]. Rev Prat (1973) 0.75
[The treatment of hematurias in hemophiliacs: study of 62 cases in 40 hemophiliacs]. Bibl Haematol (1966) 0.75
[In-vitro "thromboplastic" activity of leukocytes and intravascular blood coagulation in leukemias]. Pathol Biol (Paris) (1972) 0.75
Hereditary hypoprothrombinaemia. True deficiency of factor II. Acta Haematol (1972) 0.75
The therapeutic use of fraction P.P.S.B. Bibl Haematol (1968) 0.75
[Circulating anticoagulants during hemophilia]. Rev Fr Transfus (1972) 0.75
Isolation and partial characterization of a human prothrombin variant: prothrombin Barcelona. Biochem Biophys Res Commun (1974) 0.75
[Circulating anticoagulants in hemophilia]. Rev Fr Transfus (1972) 0.75